| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.42 | 0.006 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.007 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.008 |